Back to User profile » Dr Midori Fujishiro
Papers published by Dr Midori Fujishiro:
Association of Glycated Hemoglobin Level with Self-Reported Chewing Problems in Elderly Community-Dwelling Individuals in Japan
Fujishiro M, Tanaka S, Watanabe K, Imatake K, Suzuki Y, Ishihara H, Tani S
Journal of Multidisciplinary Healthcare 2023, 16:1231-1238
Published Date: 2 May 2023
Impact of Female Sex on the Susceptibility to Hypernatremia Among Older Community-Dwelling Individuals in Japan
Tanaka S, Fujishiro M, Imatake K, Suzuki Y, Ishihara H, Tani S
International Journal of General Medicine 2022, 15:777-785
Published Date: 20 January 2022
Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
Ichikawa C, Tanaka S, Takubo M, Kushimoto M, Ikeda J, Ogawa K, Tsujino I, Suzuki Y, Abe M, Ishihara H, Fujishiro M
Therapeutics and Clinical Risk Management 2021, 17:463-470
Published Date: 25 May 2021
A Single Episode of Hypoglycemia as a Possible Early Warning Sign of Adrenal Insufficiency
Tanaka S, Abe M, Kohno G, Kushimoto M, Ikeda J, Ogawa K, Suzuki Y, Ishihara H, Fujishiro M
Therapeutics and Clinical Risk Management 2020, 16:147-153
Published Date: 27 February 2020
Retention of aberrant cortisol secretion in a patient with bilateral macronodular adrenal hyperplasia after unilateral adrenalectomy
Tanaka S, Fujishiro M, Nakamura Y, Hatanaka Y, Abe M
Therapeutics and Clinical Risk Management 2019, 15:337-342
Published Date: 27 February 2019
Elsberg syndrome related to varicella zoster virus infection with painless skin lesions in an elderly woman with poorly controlled type 2 diabetes mellitus
Saito H, Ebashi M, Kushimoto M, Ikeda J, Egashira F, Yamaguchi S, Watanabe K, Ogawa K, Suzuki Y, Ishihara H, Fujishiro M
Therapeutics and Clinical Risk Management 2018, 14:1951-1954
Published Date: 9 October 2018